Moving Cell And Gene Therapies Into Chronic Conditions Depends On Durability, Safety
Technologies, Trials Designed For Long-Term Efficacy, Safety
Biopharma executives discussed their strategies for treating chronic diseases during the Cell and Gene Meeting on the Mesa, including R&D and regulatory considerations.
